… This study showed that the long-term use of THC/CBD spray was generally well tolerated, …
relief of cancer-related pain with long-term use. Furthermore, patients who kept using the study …

… patients registered (28.2%) took THC:CBD for cancer-related … prior history of refractory CP
reported by the patients in this … conclusions on the long-term effectiveness of THC:CBD for this …

… A subsequent open-label extension study involving 39 patients … , with some patients
maintaining long-term (up to 2 years) … studies in patients with chronic cancer-related or …

… reports safety data from RCTs and related open-label studies … were considered to be
cancer-related and not related to … capsules, dronabinol, nabilone and THC/CBD oral capsules …

… in Cannabis sativa L plants, Δ 9 -tetrahydrocannabinol has shown promise in relieving
cancer-related pain.11… Safety and tolerability were assessed by documenting treatment-emergent …

… In another open-label extension study, 15 39 patients who … for the relief of cancer pain with
long-term use and did not seek … advanced cancer patients suffering from cancer-related pain …

… An open-label extension study to investigate the long-term safety and tolerability of THC/CBD
oromucosal spray and … cancer-related pain refractory to strong opioid analgesics. J …

… Cancer-related pain is estimated to occur in up to 60% of … ®) is an oral mucosal spray
formulated from Cannabis sativa L … Safety and tolerability were assessed by documenting …

… cannabis to patients suffering from cancer-related pains. Only clinical … open-label extension
study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray …

… or second-line therapy or for long-term treatment [1]. Nevertheless, … This was a retrospective,
open-label, parallel-group, flexible-… of patients with active cancer and/or cancer-related pain; …